These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8826100)

  • 1. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
    Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
    Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
    Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of onchocerciasis. XV. Studies with albendazole.
    Awadzi K; Hero M; Opoku O; Büttner DW; Gilles HM
    Trop Med Parasitol; 1991 Dec; 42(4):356-60. PubMed ID: 1796233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela.
    Cline BL; Hernandez JL; Mather FJ; Bartholomew R; De Maza SN; Rodulfo S; Welborn CA; Eberhard ML; Convit J
    Am J Trop Med Hyg; 1992 Oct; 47(4):512-20. PubMed ID: 1443350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics.
    Awadzi K; Hero M; Opoku NO; Büttner DW; Coventry PA; Prime MA; Orme ML; Edwards G
    Trop Med Parasitol; 1994 Sep; 45(3):203-8. PubMed ID: 7899788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
    Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
    Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
    Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
    Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT; Lazdins-Helds JK; Ahmed K; Boatin BA; Boakye DA; Edwards G
    Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.
    Greene BM; Dukuly ZD; Muñoz B; White AT; Pacqué M; Taylor HR
    J Infect Dis; 1991 Feb; 163(2):376-80. PubMed ID: 1988521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin treatment of ocular onchocerciasis.
    Taylor HR
    Acta Leiden; 1990; 59(1-2):201-6. PubMed ID: 2198751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
    Awadzi K; Opoku NO; Addy ET; Quartey BT
    Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological examination of onchocercomata after therapy with ivermectin.
    Albiez EJ; Walter G; Kaiser A; Ranque P; Newland HS; White AT; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Jun; 39(2):93-9. PubMed ID: 3175472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
    Burnham G
    Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.